Cargando…

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Background: Local control following trimodality therapy (TMT) for muscle-invasive bladder cancer (MIBC) requires further optimization. Objective: Evaluating the biologic endpoint, feasibility, and toxicity of integrating everolimus to TMT in patients with MIBC. Methods: This was a phase I trial in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachir, Bassel G., Souhami, Luis, Mansure, Jose João, Cury, Fabio, Vanhuyse, Marie, Brimo, Fadi, Aprikian, Armen G., Tanguay, Simon, Sturgeon, Jeremy, Kassouf, Wassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409045/
https://www.ncbi.nlm.nih.gov/pubmed/28516155
http://dx.doi.org/10.3233/BLC-160090